XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

XBiotech Inc.

XBiotech is a biopharmaceutical company that develops therapeutic antibodies for treating inflammatory conditions, infectious diseases, and cancer.

COM:XBIOTECH

XBiotech

Last Close

6.49

21/11 21:00

Market Cap

201.80M

Beta: -

Volume Today

30.68K

Avg: -